Chemoinformaics analysis of GANODERIC-ACID-V-1
| Molecular Weight | 512.731 | nRot | 6 |
| Heavy Atom Molecular Weight | 464.347 | nRig | 23 |
| Exact Molecular Weight | 512.35 | nRing | 4 |
| Solubility: LogS | -4.656 | nHRing | 0 |
| Solubility: LogP | 5.205 | No. of Aliphatic Rings | 4 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 85 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 89.4561 |
| nHD | 2 | BPOL | 51.6259 |
| QED | 0.305 |
| Synth | 5.321 |
| Natural Product Likeliness | 3.481 |
| NR-PPAR-gamma | 0.967 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.091 |
| Pgp-sub | 0.002 |
| HIA | 0.084 |
| CACO-2 | -4.907 |
| MDCK | 0.0000129 |
| BBB | 0.467 |
| PPB | 0.990924 |
| VDSS | 0.807 |
| FU | 0.0386202 |
| CYP1A2-inh | 0.006 |
| CYP1A2-sub | 0.116 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.894 |
| CYP2c9-inh | 0.07 |
| CYP2c9-sub | 0.782 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.223 |
| CYP3a4-inh | 0.197 |
| CYP3a4-sub | 0.347 |
| CL | 3.321 |
| T12 | 0.065 |
| hERG | 0.022 |
| Ames | 0.003 |
| ROA | 0.025 |
| SkinSen | 0.608 |
| Carcinogencity | 0.205 |
| EI | 0.01 |
| Respiratory | 0.919 |
| NR-Aromatase | 0.764 |
| Antiviral | Yes |
| Prediction | 0.707574 |